Welcome!
To use the personalized features of this site, please log in or register.
If you have forgotten your username or password, we can help.
|
 |
Early Equivalence of Uncemented Press-fit and Compress® Femoral Fixation
| |
|
Symposium: Selected Papers Presented at the 2008 Meeting of the Musculoskeletal Tumor Society
Early Equivalence of Uncemented Press-fit and Compress® Femoral Fixation
German L. Farfalli1, Patrick J. Boland1, Carol D. Morris1, Edward A. Athanasian1 and John H. Healey1 
| (1) |
Orthopaedic Surgery Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center (Affiliated with Weill Medical College of Cornell University), 1275 York Avenue, Suite A342, New York, NY 10021, USA |
Received: 2 December 2008 Accepted: 19 May 2009 Published online: 10 June 2009
Abstract Bone ingrowth promises more durable biologic fixation of megaprostheses. The relative performance of different types of fixation
is unknown. We compared the fixation of two forms of biologically fixed femoral components: an intramedullary uncemented press-fit
stem (UCS; Group 1, 50 patients) and a Compress® uncemented fixation (CPS; Group 2, 41 patients). In Group 1, the overall
Kaplan-Meier prosthetic survival rates were 85% at 5 and 71% at 10 years. Most failures were long-term developments. Aseptic
loosening was the primary cause of failure. Stem diameters less than 13.5 mm and a diaphyseal/stem coefficient greater than
2.5 mm were associated with decreased prosthetic survival. In Group 2, the overall rate of CPS survival was 88% at 5 years.
Failure of femoral fixation or fracture during the first year was the main reason for revision. Five-year survival rates were
similar between the groups and we observed no difference in the functional success of the implants. We found no failures after
1-year followup in Group 2 (CPS). Any difference in prosthetic survival can only be proven by longer-term study or a randomized
trial.
Level of Evidence: Level III, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.
Each author certifies that he or she has no commercial associations (eg, consultancies, stock ownership, equity interest,
patent/licensing arrangements, etc) that might pose a conflict of interest in connection with the submitted article.
Each author certifies that his institution has approved the reporting of this study and that all investigations were conducted
in conformity with ethical principles of research.
References
| 1. |
Avedian R, Goldsby RE, Kramer MJ, O’Donnell RJ. Effect of chemotherapy on initial compressive osseointegration of oncologic
endoprostheses. Clin Orthop Relat Res. 2007;459:48–53.
|
| |
| 2. |
Bhangu AA, Kramer MJ, Grimer RJ, O’Donnell RJ. Early distal femoral endoprosthetic survival: cemented stems versus the Compress®
implant. Int Orthop. 2006;30:465–472.
|
| |
| 3. |
Bickels J, Wittig JC, Kollender Y, Henshaw RM, Kellar-Graney KL, Meller I, Malawer M. Distal femoral resection with endoprosthetic
reconstruction: a long-term followup study. Clin Orthop Relat Res. 2002;400:225–235.
|
| |
| 4. |
Bini SA, Johnston JO, Martin DL. Compliant prestress fixation in tumor prostheses: interface retrieval data. Orthopedics. 2000;23:707–712.
|
| |
| 5. |
Capanna R, Morris HG, Campanacci D, Del Ben M, Campanacci M. Modular uncemented prosthetic reconstruction after resection
of tumours of the distal femur. J Bone Joint Surg Br. 1994;76:178–186.
|
| |
| 6. |
Cristofolini L, Bini SA, Toni A. In vitro testing of a novel limb salvage prosthesis for the distal femur. Clin Biomech. 1998;13:608–615.
|
| |
| 7. |
Enneking WF, Dunham W, Gebhardt MC, Malawer M, Pritchard DJ. A system for the functional evaluation of reconstructive procedures
after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res. 1993;286:241–246.
|
| |
| 8. |
Finn HA, Simon MA. Limb-salvage surgery in the treatment of osteosarcoma in skeletally immature individuals. Clin Orthop Relat Res. 1991;262:108–118.
|
| |
| 9. |
Flint MN, Griffin AM, Bell RS, Ferguson PC, Wunder JS. Aseptic loosening is uncommon with uncemented proximal tibia tumor
prostheses. Clin Orthop Relat Res. 2006;450:52–59.
|
| |
| 10. |
Freedman EL, Eckardt JJ. A modular endoprosthetic system for tumor and non-tumor reconstruction: preliminary experience. Orthopedics. 1997;20:27–36.
|
| |
| 11. |
Griffin AM, Parsons JA, Davis AM, Bell RS, Wunder JS. Uncemented tumor endoprostheses at the knee: root causes of failure.
Clin Orthop Relat Res. 2005;438:71–79.
|
| |
| 12. |
Healey JH, Abdeen A, Morris CD, Athanasian EA, Boland PJ. Telescope allograft method to reconstitute the diaphysis in limb
salvage surgery. Clin Orthop Relat Res. 2008 Oct 3 [Epub ahead of print].
|
| |
| 13. |
Horowitz SM, Glasser DB, Lane JM, Healey JH. Prosthetic and extremity survivorship after limb salvage for sarcoma: how long
do the reconstructions last? Clin Orthop Relat Res. 1993;293:280–286.
|
| |
| 14. |
Jeys LM, Kulkarni A, Grimer RJ, Carter SR, Tillman RM, Abudu A. Endoprosthetic reconstruction for the treatment of musculoskeletal
tumors of the appendicular skeleton and pelvis. J Bone Joint Surg Am. 2008;90:1265–1271.
|
| |
| 15. |
Kawai A, Healey JH, Boland PJ, Athanasian EA, Jeon DG. A rotating-hinge knee replacement for malignant tumors of the femur
and tibia. J Arthroplasty. 1999;14:187–196.
|
| |
| 16. |
Kawai A, Lin PP, Boland PJ, Athanasian EA, Healey JH. Relationship between magnitude of resection, complication, and prosthetic
survival after prosthetic knee reconstructions for distal femoral tumors. J Surg Oncol. 1999;70:109–115.
|
| |
| 17. |
Kawai A, Muschler GF, Lane JM, Otis JC, Healey JH. Prosthetic knee replacement after resection of a malignant tumor of the
distal part of the femur. Medium to long-term results. J Bone Joint Surg Am. 1998;80:636–647.
|
| |
| 18. |
Kneisl JS, Finn HA, Simon MA. Mobile knee reconstructions after resection of malignant tumors of the distal femur. Orthop Clin N Am. 1991;22:105–119.
|
| |
| 19. |
Kramer MJ, Tanner BJ, Horvai AE, O’Donnell RJ. Compressive osseointegration promotes viable bone at the endoprosthetic interface:
retrieval study of Compress(R) implants. Int Orthop. 2008;32:567–571.
|
| |
| 20. |
Laverdiere C, Kolb EA, Supko JG, Gorlick R, Meyers PA, Maki RG, Wexler L, Demetri GD, Healey JH, Huvos AG, Goorin AM, Bagatell
R, Ruiz-Casado A, Guzman C, Jimeno J, Harmon D. Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent
osteosarcoma. Cancer. 2003;98:832–840.
|
| |
| 21. |
Marshall AD, Mokris JG, Reitman RD, Dandar A, Mauerhan DR. Cementless titanium tapered-wedge femoral stem: 10- to 15-year
follow-up. J Arthroplasty. 2004;19:546–552.
|
| |
| 22. |
Meding JB, Keating EM, Ritter MA, Faris PM, Berend ME. Minimum ten-year follow-up of a straight-stemmed, plasma-sprayed, titanium-alloy,
uncemented femoral component in primary total hip arthroplasty. J Bone Joint Surg Am. 2004;86:92–97.
|
| |
| 23. |
Meyers PA, Gorlick R, Heller G, Casper E, Lane J, Huvos AG, Healey JH. Intensification of preoperative chemotherapy for osteogenic
sarcoma: results of the Memorial Sloan-Kettering (T12) protocol. J Clin Oncol. 1998;16:2452–2458.
|
| |
| 24. |
Meyers PA, Heller G, Healey J, Huvos A, Lane J, Marcove R, Applewhite A, Vlamis V, Rosen G. Chemotherapy for nonmetastatic
osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol. 1992;10:5–15.
|
| |
| 25. |
Meyers PA, Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, Conrad E, Ferguson W, Gebhardt M, Goorin AM, Harris
MB, Healey J, Huvos A, Link M, Montebello J, Nadel H, Nieder M, Sato J, Siegal G, Weiner M, Wells R, Wold L, Womer R, Grier
H. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin,
and high-dose methotrexate. J Clin Oncol. 2005;23:2004–2011.
|
| |
| 26. |
Mittermayer F, Krepler P, Dominkus M, Schwameis E, Sluga M, Heinzl H, Kotz R. Long-term followup of uncemented tumor endoprostheses
for the lower extremity. Clin Orthop Relat Res. 2001;388:167–177.
|
| |
| 27. |
Mittermeyer F, Windhager R, Dominkus M, Krepler P, Schwamels E, Sluga M, Kotz R, Strasser G. Revision of the Kotz type of
tumor endoprosthesis for the lower limb. J Bone Joint Surg Br. 2002;84:401–406.
|
| |
| 28. |
Muscolo DL, Ayerza MA, Aponte-Tinao LA, Ranalletta M. Use of distal femoral osteoarticular allografts in limb salvage surgery.
J Bone Joint Surg Am. 2005;87:2449–2455.
|
| |
| 29. |
Sanjay BKS, Moreau P. Limb salvage surgery in bone tumour with modular endoprosthesis. Int Orthop. 1999;23:41–46.
|
| |
| 30. |
Shih LY, Sim FH, Pritchard DJ, Rock MG, Chao EY. Segmental total knee arthroplasty after distal femoral resection for tumor.
Clin Orthop Relat Res. 1993;292:269–281.
|
| |
| 31. |
Torbert JT, Fox EJ, Hosalkar HS, Ogilvie CM, Lackman RD. Endoprosthetic reconstructions: results of long-term followup of
139 patients. Clin Orthop Relat Res. 2005;438:51–59.
|
| |
| 32. |
Unwin PS, Cannon SR, Grimer RJ, Kemp HBS, Sneath RS, Walker PS. Aseptic loosening in cemented custom-made prosthetic replacements
for bone tumours of the lower limb. J Bone Joint Surg Br. 1996;78:5–13.
|
| |
| 33. |
Wunder JS, Leitch K, Griffin AM, Davis AM, Bell RS. Comparison of two methods of reconstruction for primary malignant tumors
at the knee: a sequential cohort study. J Surg Oncol. 2001;77:89–99.
|
| |
| 34. |
Zwart HJ, Taminiau AH, Schimmel JW, van Horn JR. Kotz modular femur and tibia replacement. 28 tumor cases followed for 3 (1–8)
years. Acta Orthop Scand. 1994;65:315–318.
|
| |
|
|
|
|
|
|